Frontiers in Oncology | Cancer Molecular Targets and Therapeutics

Original Research

Published on 11 Apr 2023

Clinically relevant glioblastoma patient-derived xenograft models to guide drug development and identify molecular signatures

in Cancer Molecular Targets and Therapeutics

Joshua Alcaniz
Lars Winkler
Mathias Dahlmann
Michael Becker
Andrea Orthmann
Johannes Haybaeck
Stefanie Krassnig
Christina Skofler
Tobias Kratzsch
Susanne A. Kuhn

Frontiers in Oncology

doi 10.3389/fonc.2023.1129627

6,698 views
12 citations

Review

Published on 03 Apr 2023

UPS: Opportunities and challenges for gastric cancer treatment

in Cancer Molecular Targets and Therapeutics

Hang Yang
Huihan Ai
Jialin Zhang
Jie Ma
Kangdong Liu
Zhi Li

Frontiers in Oncology

doi 10.3389/fonc.2023.1140452

4,201 views
3 citations

Original Research

Published on 03 Apr 2023

Genomic landscape and efficacy of HER2-targeted therapy in patients with HER2-mutant non-small cell lung cancer

in Cancer Molecular Targets and Therapeutics

Yanjie Han
Yuanyuan Xiong
Tao Lu
Rongrong Chen
Yuan Liu
Hui Tang
Ruixuan Geng
Yingyi Wang

Frontiers in Oncology

doi 10.3389/fonc.2023.1121708

4,241 views
3 citations

Original Research

Published on 03 Apr 2023

Synthetic oleanane triterpenoids suppress MYB oncogene activity and sensitize T-cell acute lymphoblastic leukemia cells to chemotherapy

in Cancer Molecular Targets and Therapeutics

Paloma Tejera Nevado
Tajana Tešan Tomić
Ali Atefyekta
André Fehr
Göran Stenman
Mattias K. Andersson

Frontiers in Oncology

doi 10.3389/fonc.2023.1126354

2,513 views
4 citations

Case Report

Published on 30 Mar 2023

Case report: Obstructive jaundice caused by biliary cystadenoma

in Cancer Molecular Targets and Therapeutics

Yun-cheng Li
An-da Shi
Kang-shuai Li

Frontiers in Oncology

doi 10.3389/fonc.2023.1165979

3,368 views
2 citations

Original Research

Published on 28 Mar 2023

Over-expression of RRM2 predicts adverse prognosis correlated with immune infiltrates: A potential biomarker for hepatocellular carcinoma

in Cancer Molecular Targets and Therapeutics

Zhongqiang Qin
Bo Xie
Jingyu Qian
Xiang Ma
Lan Zhang
Jianzhu Wei
Zhaoying Wang
Longfei Fan
Ziyi Zhu
Zhen Qian

Frontiers in Oncology

doi 10.3389/fonc.2023.1144269

3,340 views
10 citations

Review

Published on 28 Mar 2023

Long noncoding RNA SNHG15: A promising target in human cancers

in Cancer Molecular Targets and Therapeutics

Niu Zhang
Tianyao Lei
Tianwei Xu
Xiaoteng Zou
Zhaoxia Wang

Frontiers in Oncology

doi 10.3389/fonc.2023.1108564

2,353 views
6 citations

Systematic Review

Published on 27 Mar 2023

Acupuncture therapies for cancer-related fatigue: A Bayesian network meta-analysis and systematic review

in Cancer Molecular Targets and Therapeutics

Hao Tian
Yunhui Chen
Mingsheng Sun
Liuyang Huang
Guixing Xu
Chunyang Yang
Qin Luo
Ling Zhao
Zheng Wei
Fanrong Liang

Frontiers in Oncology

doi 10.3389/fonc.2023.1071326

5,308 views
5 citations

Original Research

Published on 27 Mar 2023

Molecular subtypes based on centrosome-related genes can predict prognosis and therapeutic responsiveness in patients with low-grade gliomas

in Cancer Molecular Targets and Therapeutics

Ganghua Zhang
Panpan Tai
Jianing Fang
Aiyan Chen
Xinyu Chen
Ke Cao

Frontiers in Oncology

doi 10.3389/fonc.2023.1157115

2,524 views
4 citations

Review

Published on 27 Mar 2023

MACC1-induced migration in tumors: Current state and perspective

in Cancer Molecular Targets and Therapeutics

Tim Hohmann
Urszula Hohmann
Faramarz Dehghani

Frontiers in Oncology

doi 10.3389/fonc.2023.1165676

2,321 views
6 citations

Original Research

Published on 24 Mar 2023

LncRNA LBX2-AS1 impacts osteosarcoma sensitivity to JQ-1 by sequestering miR-597-3p away from BRD4

in Cancer Molecular Targets and Therapeutics

Jiayu Li
Xuhui Yuan
Cong Ma
Junhong Li
Gaoyang Qu
Bo Yu
Feng Cai
Yuanxiang Peng
Lang Liu
Duo Zeng

Frontiers in Oncology

doi 10.3389/fonc.2023.1139588

2,187 views
2 citations

Review

Published on 24 Mar 2023

Application status and future prospects of the PDX model in lung cancer

in Cancer Molecular Targets and Therapeutics

Wei Liu
Yishuang Cui
Xuan Zheng
Kunpeng Yu
Guogui Sun

Frontiers in Oncology

doi 10.3389/fonc.2023.1098581

4,344 views
8 citations

Brief Research Report

Published on 23 Mar 2023

B cells as modulators of HPV+ oropharyngeal cancer in a preclinical model

in Cancer Molecular Targets and Therapeutics

Jorge R. Galán-Ortíz
Kamila A. Andino del Valle
Abelardo A. Pérez-Rosario
Daniel L. Castañón Pereira
Jennifer Díaz-Rivera
Pamela A. Merheb-Finianos
Stephanie M. Dorta-Estremera

Frontiers in Oncology

doi 10.3389/fonc.2023.1145724

2,146 views
1 citation

Case Report

Published on 23 Mar 2023

Case Report: Clinical response to anaplastic lymphoma kinase inhibitor-based targeted therapy in uterine inflammatory myofibroblastic tumor harboring ALK-IGFBP5 fusion

in Cancer Molecular Targets and Therapeutics

Ting Zhao
Xiaowei Zhang
Xin Liu
Min Ren
Yufan Cheng
Jian Wang
Zhiguo Luo

Frontiers in Oncology

doi 10.3389/fonc.2023.1147974

2,541 views
4 citations

Editorial

Published on 22 Mar 2023

Editorial: Pulsed electric field based technologies for oncology applications

in Cancer Molecular Targets and Therapeutics

Siqi Guo
Gregor Sersa
Richard Heller

Frontiers in Oncology

doi 10.3389/fonc.2023.1183900

3,214 views
7 citations

Case Report

Published on 22 Mar 2023

Case report: Epithelioid inflammatory myofibroblastic sarcoma treated with an ALK TKI ensartinib

in Cancer Molecular Targets and Therapeutics

Mengmeng Li
Ruyue Xing
Jiuyan Huang
Chao Shi
Chunhua Wei
Huijuan Wang

Frontiers in Oncology

doi 10.3389/fonc.2023.1084456

3,291 views
9 citations